Literature DB >> 25664001

Inhibition of synaptophysin ubiquitination may improve the intelligent drop due to high glucose and hypoxia.

Qiang Li1, Xiao-Long Zhu1, Ai-Ping Jin1, Xue-Yuan Liu1, Yan-Xin Zhao1.   

Abstract

Synaptophysin (SYP) is a synaptic vesicle membrane protein and involved in the release of neurotransmitters, synaptic plasticity, and formation and recycling of synaptic vesicles. SYP may serve as a specific marker of synaptic proteins. Our results showed high glucose and hypoxia could significantly impair the intelligence and the SYP level was positively related to the degree of intelligence in animals. Ubiquitination may influence the SYP expression. In our study, an ubiquitination inhibitor (MG-132) was injected intraperitoneally. Results showed this could increase SYP expression in the brain to improve the intelligent drop due to high glucose and hypoxia in animals. SYP ubiquitination is closely associated with E3 ubiquitin ligase, a mammalian homologue of seven in absentia. In our study, lentivirus expressing siah shRNA was injected into the cerebral ventricle to down-regulate siah expression, and results showed the SYP expression in the brain increased markedly. In addition, we also found that VitK3 could increase the SYP expression in the brain to improve the intelligent drop due to high glucose and hypoxia.

Entities:  

Keywords:  Synaptophysin; high glucose; hypoxia; shRNA; ubiquitination

Year:  2014        PMID: 25664001      PMCID: PMC4307448     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

1.  Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes.

Authors:  C M Ryan; M O Geckle
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

Review 2.  Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?

Authors:  C M Ryan; M Geckle
Journal:  Diabetes Metab Res Rev       Date:  2000 Sep-Oct       Impact factor: 4.876

Review 3.  Hypoxia and neurodegeneration.

Authors:  Chris Peers; Mark L Dallas; Hannah E Boycott; Jason L Scragg; Hugh A Pearson; John P Boyle
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

4.  Synaptophysin immunocytochemistry with thermal intensification: a marker of terminal axonal maturation in the human fetal nervous system.

Authors:  H B Sarnat; D E Born
Journal:  Brain Dev       Date:  1999-01       Impact factor: 1.961

5.  NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.

Authors:  P K Elias; M F Elias; R B D'Agostino; L A Cupples; P W Wilson; H Silbershatz; P A Wolf
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

6.  Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents.

Authors:  S Saito; S Kobayashi; Y Ohashi; M Igarashi; Y Komiya; S Ando
Journal:  J Neurosci Res       Date:  1994-09-01       Impact factor: 4.164

7.  NMDA receptor activation results in PKA- and ERK-dependent Mnk1 activation and increased eIF4E phosphorylation in hippocampal area CA1.

Authors:  Jessica L Banko; Lingfei Hou; Eric Klann
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

8.  Translational control by MAPK signaling in long-term synaptic plasticity and memory.

Authors:  Raymond J Kelleher; Arvind Govindarajan; Hae-Yoon Jung; Hyejin Kang; Susumu Tonegawa
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

9.  Decreased cognitive function in aging non-insulin-dependent diabetic patients.

Authors:  L C Perlmuter; M K Hakami; C Hodgson-Harrington; J Ginsberg; J Katz; D E Singer; D M Nathan
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

10.  The topogenic fate of the polytopic transmembrane proteins, synaptophysin and connexin, is determined by their membrane-spanning domains.

Authors:  R E Leube
Journal:  J Cell Sci       Date:  1995-03       Impact factor: 5.285

View more
  5 in total

1.  Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.

Authors:  Chan Chen; Jie-Zhong Yu; Qiong Zhang; Yong-Fei Zhao; Chun-Yun Liu; Yan-Hua Li; Wan-Fang Yang; Cun-Gen Ma; Bao-Guo Xiao
Journal:  Neuromolecular Med       Date:  2015-10-19       Impact factor: 3.843

2.  Reactive mesoporous silica nanoparticles loaded with limonene for improving physical and mental health of mice at simulated microgravity condition.

Authors:  Zhiguo Lu; Jianze Wang; Lina Qu; Guanghan Kan; Tianlu Zhang; Jie Shen; Yan Li; Jun Yang; Yunwei Niu; Zuobing Xiao; Yinghui Li; Xin Zhang
Journal:  Bioact Mater       Date:  2020-07-22

3.  Sevoflurane Acts on Ubiquitination-Proteasome Pathway to Reduce Postsynaptic Density 95 Protein Levels in Young Mice.

Authors:  Han Lu; Ning Liufu; Yuanlin Dong; Guanghong Xu; Yiying Zhang; Liqi Shu; Sulpicio G Soriano; Hui Zheng; Buwei Yu; Zhongcong Xie
Journal:  Anesthesiology       Date:  2017-12       Impact factor: 7.892

4.  Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice.

Authors:  Simo Siyanda Zulu; Oualid Abboussi; Nicola Simola; Musa Vuyisile Mabandla; William Mark Uren Daniels
Journal:  J Neurovirol       Date:  2021-03-12       Impact factor: 2.643

5.  Brain-derived neurotrophic factor inhibits hyperglycemia-induced apoptosis and downregulation of synaptic plasticity-related proteins in hippocampal neurons via the PI3K/Akt pathway.

Authors:  Yuan Zhong; Yitong Zhu; Ting He; Wei Li; Qinjie Li; Ya Miao
Journal:  Int J Mol Med       Date:  2018-10-15       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.